Navigation Links
Why a common treatment for prostate cancer ultimately fails
Date:8/21/2008

port cells known as stromal cells stimulates growth of cells, including cancer cells, in the prostate. He also found, surprisingly, that the receptor actually acts as a tumor suppressor in epithelial cells known as basal cells in the prostate.

Then Chang's team knocked out the androgen receptor in specific sets of prostate cells and studied the results. As expected, when the molecule is turned off in stromal cells, growth of cancer cells in the prostate slows. But when the molecule is turned off in the epithelial cells, it removes one of the body's natural inhibitors that prevents prostate cancer cells from spreading, making cells more likely to invade other tissues.

"While the androgen receptor is really driving prostate cancer, in another sense it appears that the receptor also normally inhibits the spread of cancer cells. It seems to have a dual role. Manipulating the androgen receptor can increase or decrease either of these actions depending on precisely how it's done," said Messing.

Chang says the molecule's versatility in the prostate should not come as a surprise, since the molecule's function elsewhere depends on its location.

"The effects of the androgen receptor on hair growth in men vary dramatically depending on where in the body the receptor is working," said Chang. "When the receptor is very active in the mustache area, more hair grows. When it's very active on the top of the skull, toward the front, hair falls out and men become bald. And the hair on the back of the head is insensitive to the receptor. The effects of hormones depend on the location.

"We found that the same is true within the cells of the prostate itself," said Chang, who is a faculty member in the departments of Urology and Pathology and the James P. Wilmot Cancer Center.

Chang says it's likely that the androgen receptor works differently in different cells partly because the assortment of molecular colleagues it works with within
'/>"/>

Contact: Leslie White
Leslie_White@urmc.rochester.edu
585-273-1119
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Risk of common vaginal infection linked to preterm birth appears higher for blacks
2. Features of replication suggest viruses have common themes, vulnerabilities
3. Genetics determine optimal drug dose of common anticoagulant
4. All eukaryotic kinases share 1 common set of substrates
5. 60 second test could help early diagnosis of common brain diseases
6. Soy isoflavone may inhibit common gastrointestinal illness in infants
7. The importance of gene regulation for common human disease
8. Genes and environment grant funds close look at nature-nurture overlap in common diseases
9. Thriving hybrid salamanders contradict common wisdom
10. UCI researchers restore memory process in most common form of mental disability
11. Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2015)... , May 14, 2015  Verificient ... identity verification and online remote proctoring, announced ... software-as-a-service (SaaS) company and creator of the ... of the two companies will benefit from ... Canvas. As a fully integrated ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/7/2015)... Fingerprint Cards (FPC) introduces ... FPC,s smallest touch fingerprint sensors to date.  ... integration on the backside of the phone, and ... to integrate touch fingerprint sensors in the OEMs, ... for module manufacturers to customize the look and ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... the aid of a straightforward experiment, researchers have provided ... how ancient organic molecules came together to form the ... online this week in JBC , demonstrated how ... length. RNA, the single-stranded precursor to DNA, normally ...
... ON A new technology that could help physicians ... and potentially fatal complication called preeclampsia has been developed ... Health Research Institute of Lawson Health Research Institute. ... have changed levels in the placenta of women who ...
... Institute of Ultrasound in Medicine (AIUM) 2009 Annual Convention ... Marquis Hotel in New York City, New York, Thursday ... numbers indicate that 2009 will prove to be better ... regarded as the AIUM,s most successful convention in history. ...
Cached Biology News:New technology aims to reduce maternal and neonatal deaths 2AIUM to Host 2009 Annual Convention in New York 2
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... King of Prussia, PA (PRWEB) May 21, 2015 ... that Julia O’Neill has joined the firm as senior ... more than 30 years of experience in the management ... the vaccines, biologics, pharmaceutical and chemical industries. , “We’re ... enhance our longstanding capabilities in data analytics,” said Dr. ...
(Date:5/20/2015)...  Select Medical Corporation ("Select") (NYSE: SEM ... early termination of the waiting period under the ... amended, applicable to the acquisition of Concentra Inc. ... that Select has created with Welsh, Carson, Anderson & ... MJ Acquisition Corporation has signed a definitive purchase ...
(Date:5/20/2015)... May 20, 2015  Haemonetics Corporation (NYSE: HAE ... & CEO, will present at The Jefferies 2015 Global ... on June 1 st , 2015 at 8:30am Eastern ... Concannon,s presentation live via webcast at: http://wsw.com/webcast/jeff88/hae ... HAE ) is a global healthcare company dedicated ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... Good Start Genetics ,™ Inc., an innovative molecular diagnostics company ... today announced it completed the initial closing of a $14 ... existing investors OrbiMed Advisors , Safeguard Scientifics, Inc. ... Sciences . Proceeds from this financing will be used to ...
... Corporation (NASDAQ: LIFE ) will exhibit ... cancer research during the American Association of Cancer Research ... April 4, in Chicago, Illinois. In addition, several of ... "From basic discovery of biomarkers to validation of ...
... of physicists at UC Santa Barbara has seen the light, ... and low-frequency laser beams at a semiconductor, the researchers caused ... smashed back into the cores they left behind. This recollision ... the current issue of the science journal Nature . ...
Cached Biology Technology:Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 2Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 3Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 4Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 5Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 2Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 3Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 4Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 5UCSB Physicists mix 2 lasers to create light at many frequencies 2UCSB Physicists mix 2 lasers to create light at many frequencies 3
... Cell Cultures (ECACC) in conjunction with the ... of England, Bristol, UK, have produced standardised ... HER2, oestrogen and progresterone receptor assays. The ... formalin fixed, breast cancer cell lines; MDA-MD-361, ...
... When Ambion introduced the highly potent TURBO ... a new standard was set in DNA removal ... of DNase I that is much more efficient ... trace amounts of unwanted DNA. TURBO DNase binds ...
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
PP2B-Abeta (C-20)...
Biology Products: